A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival.
about
A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A novel MYD88 mutation, L265RP ...... on and enhances cell survival.
@en
A novel MYD88 mutation, L265RP ...... on and enhances cell survival.
@nl
type
label
A novel MYD88 mutation, L265RP ...... on and enhances cell survival.
@en
A novel MYD88 mutation, L265RP ...... on and enhances cell survival.
@nl
prefLabel
A novel MYD88 mutation, L265RP ...... on and enhances cell survival.
@en
A novel MYD88 mutation, L265RP ...... on and enhances cell survival.
@nl
P2093
P2860
P356
P1433
P1476
A novel MYD88 mutation, L265RP ...... ion and enhances cell survival
@en
P2093
G Oshikawa
P2860
P2888
P356
10.1038/BCJ.2015.36
P50
P577
2015-05-15T00:00:00Z
P5875
P6179
1032293797